HER2-Positive Breast Cancer Treatment Market Insights and Forecast to 2032
January 24, 2024 10:35 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...
United States IBRANCE (Palbociclib) Drug Insight and Market Forecasts Report 2023-2032
February 14, 2023 08:03 ET
|
Research and Markets
Dublin, Feb. 14, 2023 (GLOBE NEWSWIRE) -- The "IBRANCE Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering."IBRANCE Drug Insight and Market...
ActivX Biosciences reports key findings that could impact the use of clinically approved CDK4/6 inhibitors in the treatment of cancer patients
March 11, 2019 10:00 ET
|
ActivX Biosciences
LA JOLLA, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- ActivX Biosciences, Inc., a wholly-owned subsidiary of Kyorin Pharmaceutical Co., Ltd. (Tokyo), announces a report published in a high profile,...